Friday, Nov 15, 2013
Download Brochure

BioScale webinar on 20th Nov 2013: Advances in cancer research and biomarker assays in complex samples

BioScale, Inc.



Webinar with Dr. Martin Latterich, BioScale

Hong Kong timezone date: 21st November, 2013
Hong Kong Time: 12:30 am - 1:30am HKT
(EST timezone date: Wednesday 20th November, 2013
EST Time: 11:30 am - 12:30 pm EST )
Register now to get assess

Abstract: Basic and translational cancer research requires robust analytical tools for quantifying cellular signal transduction molecules or circulating cancer biomarkers in biologically complex samples. Here, we introduce a non-optical, acoustic immunoassay platform that scientists use for applications as diverse as comparing the activation and inactivation of signal transduction nodes upon drug delivery to measure cancer biomarkers in plasma of cancer patients. We will discuss the additional benefits of non-optical assays in the quantification of biomarkers in heme-containing tissue extract and hemolyzed plasma.15/11/2013

Key Objectives
  • Address assay limitations with traditional ELISA assays and complex samples
  • Understand how non-optical assays enable advances in cancer research
  • Enable quantifying biomarkers in heme-containing and hemolyzed samples
  • Hands-free assay automation for up to 288 samples in one run
  • Benefits of developing your own biomarker assays - days vs months

For more information, please contact us or visit www.bioscale.com

Top of Page

Home | About Us | What's New | Product | Promotion | Contact Us | eBiotrade.com

Copyright © 1999-2017 Gene Company Limited. All Rights Reserved.